Status:

TERMINATED

Modafinil in Opioid Induced Sedation

Lead Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions:

Cancer

Pain

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

* The primary objective of this study is to evaluate the efficacy of modafinil in the treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS). * The secondary objective ...

Detailed Description

Sedation is a common side effect of opioid analgesics. In patients where this remains a dose limiting toxicity, stimulants (caffeine, methylphenidate, ephedrine, amphetamine) have been the primary cla...

Eligibility Criteria

Inclusion

  • Epworth Sleepiness Scale \> 10
  • Etiology of sleepiness is attributed only to opioids
  • Patient must have been taking an opioid for more than 2 weeks or have been on a non-escalating dose of opioids for at least 1 week
  • Patient must be able to give written informed consent
  • Age \>18 years

Exclusion

  • Hypersensitivity to modafinil
  • Mini-Mental Status Exam (MMSE) \< 25/30
  • Renal impairment (calculated creatinine clearance \< 40)
  • Hepatic dysfunction (total bilirubin \> 1.8, AST \> 75IU/l, ALT \> 100IU/l, prothrombin time \> 40%
  • Known history of cardiovascular disease (i.e., left ventricular hypertrophy, ischemic ECG changes, chest pain, arrhythmia, mitral valve prolapse, recent myocardial infarction, unstable angina, uncontrolled hypertension)
  • Woman who are pregnant, breast-feeding or on hormonal contraception
  • Patients taking tricyclic antidepressants, CNS stimulants, hormonal contraceptives or drugs that are inhibitors or inducers of CYP 3A4

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

End Date :

December 1 2006

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00267332

Start Date

January 1 2006

End Date

December 1 2006

Last Update

May 7 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Johns Hopkins Hospital

Baltimore, Maryland, United States, 21205